Spots Global Cancer Trial Database for fianlimab
Every month we try and update this database with for fianlimab cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Neoadjuvant Cemiplimab for the Treatment of Resectable NSCLC, HCC, and HNSCC in Adult Patients | NCT03916627 | Non-small Cell ... Hepatocellular ... Head and Neck S... | cemiplimab Platinum Double... fianlimab | 18 Years - | Regeneron Pharmaceuticals | |
| Study of Cemiplimab Alone or in Combination With Fianlimab and/or Other Experimental Agents in Adult Participants With Peri-operative Stage III/IV Cutaneous Squamous Cell Carcinoma (CSCC) | NCT06384820 | Cutaneous Squam... | cemiplimab fianlimab | 18 Years - | Regeneron Pharmaceuticals | |
| Cemiplimab With or Without Fianlimab to Treat Older Patients With Localized or Locally Advanced MSI-H Colorectal Cancer | NCT06205836 | Colorectal Canc... | Cemiplimab Fianlimab | 70 Years - | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | |
| Cemiplimab With or Without Fianlimab to Treat Older Patients With Localized or Locally Advanced MSI-H Colorectal Cancer | NCT06205836 | Colorectal Canc... | Cemiplimab Fianlimab | 70 Years - | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | |
| A Trial to Learn if the Combination of Fianlimab, Cemiplimab, and Chemotherapy is Safe and Works Better Than the Combination of Cemiplimab and Chemotherapy in Adult Patients With Non-small Cell Lung Cancer That Can be Treated With Surgery. | NCT06161441 | Resectable Non-... | Fianlimab Cemiplimab Pemetrexed Paclitaxel Carboplatin Cisplatin Placebo | 18 Years - | Regeneron Pharmaceuticals | |
| Clinical Study of Fianlimab in Combination With Cemiplimab in Adolescent and Adult Patients With Previously Untreated Unresectable Locally Advanced or Metastatic Melanoma | NCT05352672 | Melanoma | Fianlimab Cemiplimab Pembrolizumab Placebo | 12 Years - | Regeneron Pharmaceuticals | |
| A Study to Learn if a Combination of Fianlimab and Cemiplimab Versus Cemiplimab Alone is More Effective for Adult Participants With Advanced Non-Small Cell Lung Cancer (NSCLC) | NCT05785767 | Advanced Non-Sm... | fianlimab cemiplimab Placebo | 18 Years - | Regeneron Pharmaceuticals | |
| A Study to Learn if a Combination of Fianlimab and Cemiplimab Versus Cemiplimab Alone is More Effective for Adult Participants With Advanced Non-Small Cell Lung Cancer (NSCLC) | NCT05785767 | Advanced Non-Sm... | fianlimab cemiplimab Placebo | 18 Years - | Regeneron Pharmaceuticals | |
| A Trial to See if the Combination of Fianlimab With Cemiplimab Works Better Than Pembrolizumab for Preventing or Delaying Melanoma From Coming Back After it Has Been Removed With Surgery | NCT05608291 | Melanoma | Fianlimab Cemiplimab Pembrolizumab Placebo | 12 Years - | Regeneron Pharmaceuticals | |
| A Trial to Learn if Fianlimab and Cemiplimab Are Safe and Work Better Than Anti-PD1 Alone in Adult Participants With Resectable Stage 3 or 4 Melanoma | NCT06190951 | Melanoma | pembrolizumab fianlimab cemiplimab cemiplimab+fian... | 18 Years - | Regeneron Pharmaceuticals | |
| A Trial to Learn How the Combination of Fianlimab With Cemiplimab and Chemotherapy Works Compared With Cemiplimab and Chemotherapy for Treating Adult Patients With Advanced Non-small Cell Lung Cancer | NCT05800015 | Non-small Cell ... | fianlimab cemiplimab Pemetrexed Paclitaxel Carboplatin Cisplatin Placebo | 18 Years - | Regeneron Pharmaceuticals |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
